308 related articles for article (PubMed ID: 10777477)
1. Histone deacetylases specifically down-regulate p53-dependent gene activation.
Juan LJ; Shia WJ; Chen MH; Yang WM; Seto E; Lin YS; Wu CW
J Biol Chem; 2000 Jul; 275(27):20436-43. PubMed ID: 10777477
[TBL] [Abstract][Full Text] [Related]
2. Acetylation of Sirt2 by p300 attenuates its deacetylase activity.
Han Y; Jin YH; Kim YJ; Kang BY; Choi HJ; Kim DW; Yeo CY; Lee KY
Biochem Biophys Res Commun; 2008 Oct; 375(4):576-80. PubMed ID: 18722353
[TBL] [Abstract][Full Text] [Related]
3. Enhanced deacetylation of p53 by the anti-apoptotic protein HSCO in association with histone deacetylase 1.
Higashitsuji H; Higashitsuji H; Masuda T; Liu Y; Itoh K; Fujita J
J Biol Chem; 2007 May; 282(18):13716-25. PubMed ID: 17353187
[TBL] [Abstract][Full Text] [Related]
4. MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation.
Ito A; Kawaguchi Y; Lai CH; Kovacs JJ; Higashimoto Y; Appella E; Yao TP
EMBO J; 2002 Nov; 21(22):6236-45. PubMed ID: 12426395
[TBL] [Abstract][Full Text] [Related]
5. Green tea polyphenols increase p53 transcriptional activity and acetylation by suppressing class I histone deacetylases.
Thakur VS; Gupta K; Gupta S
Int J Oncol; 2012 Jul; 41(1):353-61. PubMed ID: 22552582
[TBL] [Abstract][Full Text] [Related]
6. HDAC1 acetylation is linked to progressive modulation of steroid receptor-induced gene transcription.
Qiu Y; Zhao Y; Becker M; John S; Parekh BS; Huang S; Hendarwanto A; Martinez ED; Chen Y; Lu H; Adkins NL; Stavreva DA; Wiench M; Georgel PT; Schiltz RL; Hager GL
Mol Cell; 2006 Jun; 22(5):669-79. PubMed ID: 16762839
[TBL] [Abstract][Full Text] [Related]
7. Negative regulation of bcl-2 expression by p53 in hematopoietic cells.
Wu Y; Mehew JW; Heckman CA; Arcinas M; Boxer LM
Oncogene; 2001 Jan; 20(2):240-51. PubMed ID: 11313951
[TBL] [Abstract][Full Text] [Related]
8. Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters.
Imbriano C; Gurtner A; Cocchiarella F; Di Agostino S; Basile V; Gostissa M; Dobbelstein M; Del Sal G; Piaggio G; Mantovani R
Mol Cell Biol; 2005 May; 25(9):3737-51. PubMed ID: 15831478
[TBL] [Abstract][Full Text] [Related]
9. SPRR2A enhances p53 deacetylation through HDAC1 and down regulates p21 promoter activity.
Mizuguchi Y; Specht S; Lunz JG; Isse K; Corbitt N; Takizawa T; Demetris AJ
BMC Mol Biol; 2012 Jun; 13():20. PubMed ID: 22731250
[TBL] [Abstract][Full Text] [Related]
10. Deacetylation of p53 modulates its effect on cell growth and apoptosis.
Luo J; Su F; Chen D; Shiloh A; Gu W
Nature; 2000 Nov; 408(6810):377-81. PubMed ID: 11099047
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex.
Kai L; Samuel SK; Levenson AS
Int J Cancer; 2010 Apr; 126(7):1538-48. PubMed ID: 19810103
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
[TBL] [Abstract][Full Text] [Related]
13. Deacetylase recruitment by the C/H3 domain of the acetyltransferase p300.
Simone C; Stiegler P; Forcales SV; Bagella L; De Luca A; Sartorelli V; Giordano A; Puri PL
Oncogene; 2004 Mar; 23(12):2177-87. PubMed ID: 14968110
[TBL] [Abstract][Full Text] [Related]
14. p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-kappaB subunit with histone deacetylase 1.
Rocha S; Martin AM; Meek DW; Perkins ND
Mol Cell Biol; 2003 Jul; 23(13):4713-27. PubMed ID: 12808109
[TBL] [Abstract][Full Text] [Related]
15. HDAC inhibition promotes neuronal outgrowth and counteracts growth cone collapse through CBP/p300 and P/CAF-dependent p53 acetylation.
Gaub P; Tedeschi A; Puttagunta R; Nguyen T; Schmandke A; Di Giovanni S
Cell Death Differ; 2010 Sep; 17(9):1392-408. PubMed ID: 20094059
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of histone deacetylase 1 confers resistance to sodium butyrate-mediated apoptosis in melanoma cells through a p53-mediated pathway.
Bandyopadhyay D; Mishra A; Medrano EE
Cancer Res; 2004 Nov; 64(21):7706-10. PubMed ID: 15520174
[TBL] [Abstract][Full Text] [Related]
17. Acidic domain is indispensable for MDM2 to negatively regulate the acetylation of p53.
Wang Q; Yang Y; Wang L; Zhang PZ; Yu L
Biochem Biophys Res Commun; 2008 Sep; 374(3):437-41. PubMed ID: 18638452
[TBL] [Abstract][Full Text] [Related]
18. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression.
Ashburner BP; Westerheide SD; Baldwin AS
Mol Cell Biol; 2001 Oct; 21(20):7065-77. PubMed ID: 11564889
[TBL] [Abstract][Full Text] [Related]
19. Histone modifications affect differential regulation of TGFβ- induced NADPH oxidase 4 (NOX4) by wild-type and mutant p53.
Boudreau HE; Ma WF; Korzeniowska A; Park JJ; Bhagwat MA; Leto TL
Oncotarget; 2017 Jul; 8(27):44379-44397. PubMed ID: 28574838
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase 2 modulates p53 transcriptional activities through regulation of p53-DNA binding activity.
Harms KL; Chen X
Cancer Res; 2007 Apr; 67(7):3145-52. PubMed ID: 17409421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
